News

Applied Clinical Trials Online2d
Investigational MK-1084 Demonstrates Antitumor Activity in Phase I Trial for Colorectal and Non-Small Cell Lung Cancers
MK-1084, Merck’s investigational KRAS G12C inhibitor, showed a manageable safety profile along with antitumor activity in the ...
Applied Clinical Trials Online2d
The Hidden Impact of Drug Pricing on Government Clinical Trials
In this video interview, Ron Lanton, partner, Lanton Law, discusses how a potential increase in drug costs could affect the ...
Applied Clinical Trials Online4d
Gilead’s Trodelvy Meets Primary Endpoint of Progression-Free Survival in Phase III ASCENT-03 Breast Cancer Study
In patients with first-line metastatic triple-negative breast cancer who are not candidates for PD-1/PD-L1 inhibitors, ...
Applied Clinical Trials Online5d
The Future of Drug Discovery: AI-Powered Predictions and Virtual Patient Models
In this video interview, Michel van Harten, MD, CEO, myTomorrows, highlights the potential of artificial intelligence in ...
Applied Clinical Trials Online5d
New Phase III Data Show Bayer’s Nubeqa Significantly Improves Quality of Life for Prostate Cancer Patients
In a post-hoc analysis from the Phase III ARANOTE trial, new results show metastatic castration-sensitive prostate cancer ...
Applied Clinical Trials Online4d
Clinical Trial Monitoring: Should Randomization Be Included?
Randomization monitoring is a type of statistical/central monitoring, which ICH notes should be performed by appropriately ...
appliedclinicaltrialsonline5d
Pimicotinib Succeeds in Phase III MANEUVER Trial, Demonstrates Meaningful Improvements in Tenosynovial Giant Cell Tumor Patients
Pimicotinib, an investigational colony stimulating factor-1 receptor inhibitor being developed by Abbisko Therapeutics and licensed by Merck KGaA, met MANEUVER’s primary endpoint of objective response ...